Cytomegalovirus infection during immunosuppressive therapy for diffuse parenchymal lung disease-Reference-Cited by-同舟云学术

Cytomegalovirus infection during immunosuppressive therapy for diffuse parenchymal lung disease

Published:2012-12-26 Issue:1 Volume:18 Page:117-124
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:

Author:

ARAI TORU,INOUE YOSHIKAZU,TACHIBANA KAZUNOBU,TSUYUGUCHI KAZUNARI,NISHIYAMA AKIHIDE,SUGIMOTO CHIKATOSHI,SASAKI YUMIKO,KAGAWA TOMOKO,MATSUDA YOSHINOBU,HAYASHI SEIJI

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1843.2012.02263.x/fullpdf

Reference28 articles.

1. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments;Gandhi;Lancet Infect. Dis.,2004

2. Rapid diagnosis of cytomegalovirus infection by direct immunoperoxidase staining with human monoclonal antibody against an immediate early antigen;Eizuru;Microbiol. Immunol.,1991

3. Monitoring and diagnosis of cytomegalovirus infection in renal transplantation;Murry;J. Am. Soc. Nephrol.,1997

4. Infection in organ-transplant recipients;Fishman;N. Engl. J. Med.,1998

5. Cytomegalovirus antigen detection in peripheral blood leucocytes after allogeneic marrow transplantation;Boeckh;Blood,1992

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical significance of cytomegalovirus (CMV) pp65 antigenemia in the prediction of CMV infection during immunosuppressive therapy for rheumatic disease;Rheumatology International;2022-08-30

2. Platelet-derived growth factor can predict survival and acute exacerbation in patients with idiopathic pulmonary fibrosis;Journal of Thoracic Disease;2022-02

3. Clinical features of dermatomyositis associated with anti-MDA5 antibodies by age;Modern Rheumatology;2020-03-30

4. Invasive fungal disease and cytomegalovirus infection;Current Opinion in Infectious Diseases;2018-12

5. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies;Respiratory Medicine;2018-07